Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of γ-glutamyl transpeptidase

American Journal of Gastroenterology

Volumn 93, Issue 9, 1998, Pages 1510-1517

  Cançado, Eduardo Luiz R ^a   Leitão, Regina Maria Cubero ^a   Carrilho, Flair José ^a   Laudanna, Antônio Atílio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; RIFAMPICIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT;

ADULT; CHILD, PRESCHOOL; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; FAMILY HEALTH; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; PRURITUS; RECURRENCE; REMISSION INDUCTION; RIFAMPIN;

EID: 0032172828     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00353-0     Document Type: Article

References (35)

1. 1. Khandelwal M, Malet PF. Pruritis associated with cholestasis. A review of pathogenesis and management. Dig Dis Sci 1994;39:1-8.
2. 2. Whitington PF, Whitington GL. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988;95:130-6.
3. 3. Poupon RE Poupon R, Balkau B. Ursadiol for long-term treatment of primary biliary cirrhosis. The UDCA-PBC study group. N Engl J Med 1994;330:1342-7.
4. 4. Bjorken I. Inborn errors of metabolism with consequences for bile acid biosynthesis. Scand J Gastroenterol 1994;29(suppl):204:68-72.
5. 5. Stiehl A. Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis. Scand J Gastroenterol 1994;29(suppl):204:59-61.
6. 6. Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990;98:1013-6.
7. 7. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind crossover controlled trial. Gastroenterology 1988;94:488-93.
8. 8. Bachs L, Parés A, Elena M, et al. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 1992; 102:2077-80.
9. 9. Podesta A, Lopez P, Terg R, et al. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci 1991;36:216-20.
10. 10. Gregorio GV, Ball CS, Mowat AP, et al. Effect of rifampicin in the treatment of pruritus in hepatic cholestasis. Arch Dis Child 1993;69: 141-3.
11. 11. Desmet VJ. Cholestasis: Extrahepatic obstruction and secondary biliary cirrhosis. In: MacSween RNM, Anthony PP, Sheuer P, eds. Pathology of the liver. Edinburgh: Churchill Lingstone, 1994:425-76.
12. 12. Maggiore G, Bernard O, Hadchouel M, et al. Diagnostic value of serum γ-glutamyl transpeptidase activity in liver diseases in children. J Pediatr Gastroenterol Nutr 1991;12:21-6.
13. 13. Colombo C. Novel aspects of neonatal cholestatic liver diseases. HRLR 1995;25:XI-XVIII.
14. 14. Brenard R, Geubel AP, Benhamou JP. Benign recurrent intrahepatic cholestasis. A report of 26 cases. J Clin Gastroenterol 1989;11:546-51.
15. 15. Sondag D, Bader R, Claude P, et al. La gamma-glutamyl transpeptidase est-elle constamment normale dans la cholestase récurrente bénigne? Gastroenterol Clin Biol 1987;11:711-2.
16. 16. Williams R, Cartter MA, Sherloch S, et al. Idiopathic recurrent cholestasis: A study of the functional and pathological lesions in four cases. Q J Med 1964;131:387-99.
17. 17. Riely CA. Familial intrahepatic cholestatic syndromes. Sem Liver Dis 1987;7:119-33.
18. 18. Whitington PF. Chronic cholestasis of infancy. Pediatr Clin North Am 1996;43:1-26.
19. 19. Jacquemin E, Hadchouel M, Congard B, et al. Cholestase gravidique et activité sérique normale de la gamma-glutamyl transpeptidase. Gastroenterol Clin Biol 1988;12:768-9 [letter].
20. 20. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin North Am 1992;21:905-21.
21. 21. Tygstrup N, Jensen B. Intermittent intrahepatic cholestasis of unknown etiology in five young males from the Faroe Islands. Acta Med Scand 1969;185:523-30.
22. 22. Putterman C, Keidar S, Brook JG. Benign recurrent intrahepatic cholestasis - 25 years of follow-up. Postgrad Med J 1987;63:295-6.
23. 23. Summerskill WHJ. The syndrome of benign recurrent cholestasis. Am J Med 1965;38:298-305.
24. 24. Parés A, Rimola A, Bruguera M, et al. Renal tubular acidosis in primary biliary cirrhosis. Gastroenterology 1981;80:681-6.
25. 25. Bachs L, Parés A, Elena M, et al. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet 1989;1:574-6.
26. 26. Wietholtz H, Marschall H-U, Sjovall J, et al. Stimulation of bile acid 6α-hydroxylation by rifampin. J Hepatol 1996;24:713-8.
27. 27. Ghent CN. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. Am J Gastroenterol 1987;82:117-8.
28. 28. Galeazzi R, Lorenzini I, Orlandi F. Rifampicin-induced elevations of serum bile acids in man. Dig Dis Sci 1980;25:108-12.
29. 29. Bolt HM, Bolt M, Kappus H. Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man. Acta Endocrinol 1977;85:189-97.
30. 30. Lønning PE, Bakke P, Thorsen T, et al. Plasma levels of estradiol, estrone, estrone sulfate and sex hormone binding globulin in patients receiving rifampicin. J Steroid Biochem 1989;33:631-5.
31. 31. Shenfield GM. Oral contraceptives. Are drug interactions of clinical significance? Drug Saf 1993;9:21-37.
32. 32. Fahal IH, Williams PS, Clark RE, et al. Thrombotic thrombocytopenic purpura due to rifampicin. BMJ 1992;304:882.
33. 33. Balsells F, Wyllie R, Steffen R, et al. Benign recurrent intrahepatic cholestasis: Improvement of pruritus and shortening of the symptomatic phase with rifampin therapy: A case report. Clin Pediatr 36:483-5.
34. 34. Kuipers F, Havinga R, Vonk RJ. Cholestasis induced by sulphated glycolithocholic acid in the rat: Protection by endogenous bile acids. Clin Sci 1985;68:127-34.
35. 35. Biljleveld CM, Vonk RJ, Kuipers F. Benign recurrent intrahepatic cholestasis: Altered bile acid metabolism. Gastroenterology 1989;97: 427-32.